Bisphosphonates are the class of drugs most frequently prescribed
for strengthening bone and reducing fractures; they are
FDA-approved for the prevention and treatment of osteoporosis. A
few women taking a this medication for several years experienced
unusual thighbone fractures, but a large Danish study did not
find sufficient evidence to support a connection.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.